{
    "Case ID": "001972",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent infringement dispute"
    ],
    "Legal_Issue": [
        "Whether Apotex's allegation of non-infringement is justified"
    ],
    "Governing_Law": [
        "Patented Medicines (Notice of Compliance) Regulations",
        "Canadian patent law"
    ],
    "Procedural_Stage": [
        "Prohibition application stage"
    ],
    "Evidence_Assessment": [
        "Experiments showing partial conversion of anhydrate to hemihydrate were deemed inconclusive due to experimental conditions and lack of specificity"
    ],
    "Decision_Outcome": [
        "SmithKline's application dismissed"
    ],
    "Burden_of_Proof": [
        "On applicant (SmithKline) to prove infringement on a balance of probabilities"
    ],
    "Credibility_Factor": [
        "Lack of specificity and reliability in experimental data"
    ],
    "Legal_Rule": [
        "A party alleging non-infringement must provide sufficient facts; the applicant must prove the allegation is not justified"
    ],
    "Standard_of_Review": [
        "Balance of probabilities"
    ],
    "Procedural_Issue": [
        "Filing of prohibition application under NOC regulations"
    ],
    "Grounds_for_Claim": [
        "Potential infringement of patented crystalline form of paroxetine hydrochloride hemihydrate"
    ],
    "Outcome_on_Merits": [
        "Apotex's non-infringement allegation is justified"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Application dismissed"
    ],
    "Review_Standard": [
        "Balance of probabilities"
    ],
    "Procedural_Fairness_Assessment": [
        "No procedural unfairness identified"
    ],
    "Key_Evidence_Considered": [
        "Experimental results",
        "Expert testimonies"
    ],
    "Legal_Framework": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Applicant_Challenge": [
        "SmithKline challenged Apotex's generic product launch"
    ],
    "Court_Result": [
        "Allowed Apotex to proceed with product launch"
    ],
    "Legal_Rule_Source": [
        "Canadian patent law"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Apotex alleged non-infringement based on insufficient evidence of conversion"
    ],
    "Evidence_Type": [
        "Experimental data",
        "Expert testimony"
    ],
    "Remedy_Requested": [
        "Prohibition of Apotex's product launch"
    ],
    "Outcome": [
        "Remedy denied; Apotex permitted to launch product"
    ],
    "Decision_Authority": [
        "Federal Court (implied by context)"
    ],
    "Remedy_Sought": [
        "Interlocutory injunction to prevent market entry"
    ],
    "Resolution_Mechanism": [
        "Judicial determination following evidentiary hearing"
    ],
    "Legal_Provision": [
        "Section 6 of the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Authority": [
        "Canadian courts"
    ],
    "Claimant_Status": [
        "Patent holder (SmithKline)"
    ],
    "Legal_Provision_Cited": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Allegation of non-infringement supported due to lack of conclusive proof"
    ],
    "Applicable_Process": [
        "NOC proceeding"
    ],
    "Outcome_of_Review": [
        "Dismissal of prohibition application"
    ],
    "Pending_Relief_or_Application": [
        "Prohibition application dismissed"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ]
}